Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sweena Parmar"'
Autor:
Shannon Moore-Langston, Yuchuan Ding, Jung Min Kim, Sweena Parmar, Vance L Fredrickson, Radhika Rastogi, Omar Elmadoun
Publikováno v:
Current Medicinal Chemistry. 22:1194-1204
Currently, stroke researchers are racing to develop neuroprotective strategies that shield the brain from ischemia-induced injury. To date, neuroprotective agents that have shown promise in animal studies have failed in clinical trials. Since the pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ebedb3f75986aaea7e712e5fda4f930
https://doi.org/10.2174/0929867322666150114152945
https://doi.org/10.2174/0929867322666150114152945
Autor:
Sweena Parmar, William A Li, Xiaokun Geng, Changya Peng, Xuemei Li, Huishan Du, Feng Ling, Tia Chakraborty, Yuchuan Ding, José A. Rafols, Xiaomu Tan, Xunming Ji, Murali Guthikonda
Publikováno v:
Brain Research. 1531:17-24
The effect of normobaric oxygen (NBO) on apoptosis remains controversial. The present study evaluated the effect of NBO on ischemia-induced apoptosis and assessed the potential for improved outcomes by combining NBO administration with another neurop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c378cffa0a6f68635e3365921cc54bef
https://doi.org/10.1016/j.brainres.2013.07.051
https://doi.org/10.1016/j.brainres.2013.07.051
Publikováno v:
Stroke. 44
Objectives: Normobaric oxygenation (NBO) has been shown to provide neuroprotection in vivo and in vitro . Yet, a recent Phase 2 clinical trial investigating NBO therapy in acute ischemic stroke was terminated due to questionable therapeutic benefit.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e3bd44ba0610bbf800e8367c784eb79
https://doi.org/10.1161/str.44.suppl_1.awp62
https://doi.org/10.1161/str.44.suppl_1.awp62